Skip to main content
logo
NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.65
-0.30 (-0.83%)
Dec 24, 2025, 1:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Transformative Therapies for Cardio-metabolic Diseases
45.56M
Log In
Log In
Transformative Therapies for Cardio-metabolic Diseases Growth
223.37%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Italy
45.56M
Log In
Log In
Italy Growth
223.37%
Log In
Log In